Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Jan 28;401(10373):250-251.
doi: 10.1016/S0140-6736(22)02593-4. Epub 2022 Dec 22.

PANORAMIC: important insights into molnupiravir use in COVID-19

Michael R Kidd  1 , Paul M Kelly  2
Affiliations
Comment

PANORAMIC: important insights into molnupiravir use in COVID-19

Michael R Kidd et al. Lancet. .
No abstract available

PubMed Disclaimer

Comment on

References

    1. Mahase E. COVID-19: Pfizer's paxlovid is 89% effective in patients at risk of serious illness, company reports. BMJ. 2021;375 - PubMed
    1. Jayk Bernal A, Gomes da Silva MM, Musungaie DB, et al. Molnupiravir for oral treatment of COVID-19 in nonhospitalized patients. N Engl J Med. 2022;386:509–520. - PMC - PubMed
    1. Wong CKH, Au ICH, Lau KTK, Lau EHY, Cowling BJ, Leung GM. Real-world effectiveness of early molnupiravir or nirmatrelvir–ritonavir in hospitalised patients with COVID-19 without supplemental oxygen requirement on admission during Hong Kong's omicron BA.2 wave: a retrospective cohort study. Lancet Infect Dis. 2022;22:1681–1693. - PMC - PubMed
    1. Arbel R, Sagy YW, Battat E, et al. Molnupiravir use and severe COVID-19 outcomes during the omicron surge. Research Square. 2022 doi: 10.21203/rs.3.rs-2115769/v1. published online Sept 29. (preprint). - DOI - PMC - PubMed
    1. Cowie B, Sutton B, Van Heer C, Majumdar S. Paxlovid is Australia's first-line COVID antiviral but Lagevrio also prevents severe disease in over-70s. 2022. https://theconversation.com/paxlovid-is-australias-first-line-covid-anti...